ZA7682B - Pharmacologically active compounds - Google Patents
Pharmacologically active compoundsInfo
- Publication number
- ZA7682B ZA7682B ZA00760082A ZA7682A ZA7682B ZA 7682 B ZA7682 B ZA 7682B ZA 00760082 A ZA00760082 A ZA 00760082A ZA 7682 A ZA7682 A ZA 7682A ZA 7682 B ZA7682 B ZA 7682B
- Authority
- ZA
- South Africa
- Prior art keywords
- active compounds
- pharmacologically active
- pharmacologically
- compounds
- active
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/32—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB4538/75A GB1542840A (en) | 1975-02-03 | 1975-02-03 | Heterocyclic dithiocarbamates and isothioureas |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA7682B true ZA7682B (en) | 1976-12-29 |
Family
ID=9779069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA00760082A ZA7682B (en) | 1975-02-03 | 1976-01-07 | Pharmacologically active compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4056621A (it) |
| JP (3) | JPS6044302B2 (it) |
| AU (1) | AU502509B2 (it) |
| BE (1) | BE837848A (it) |
| CA (1) | CA1067501A (it) |
| DE (1) | DE2604056A1 (it) |
| FR (1) | FR2299026A1 (it) |
| GB (1) | GB1542840A (it) |
| IE (1) | IE42470B1 (it) |
| NL (1) | NL7600906A (it) |
| ZA (1) | ZA7682B (it) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA782129B (en) | 1977-04-20 | 1979-03-28 | Ici Ltd | Hertocyclic derivatives |
| US4165378A (en) | 1977-04-20 | 1979-08-21 | Ici Americas Inc. | Guanidine derivatives of imidazoles and thiazoles |
| US4239908A (en) * | 1979-12-10 | 1980-12-16 | G.D. Searle & Co. | N-aralkenyl-N'-cyano-N"-(heterocyclylthioalkyl)-guanidines |
| JPS57130975A (en) * | 1981-02-06 | 1982-08-13 | Fujimoto Seiyaku Kk | Preparation of imidazole derivative |
| JPS57212165A (en) * | 1981-06-25 | 1982-12-27 | Fujimoto Seiyaku Kk | Imidazole derivative and its preparation |
| JPS57212170A (en) * | 1981-06-25 | 1982-12-27 | Fujimoto Seiyaku Kk | Production of guanidine derivative |
| JPS57212166A (en) * | 1981-06-25 | 1982-12-27 | Fujimoto Seiyaku Kk | Imidazole derivative and its preparation |
| US5807884A (en) * | 1992-10-30 | 1998-09-15 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5380747A (en) * | 1992-10-30 | 1995-01-10 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5783596A (en) * | 1992-10-30 | 1998-07-21 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5792787A (en) * | 1995-06-07 | 1998-08-11 | Emory University | Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
| US5922761A (en) * | 1996-09-06 | 1999-07-13 | Medinox, Inc. | Methods for in vivo reduction of iron levels and compositions useful therefor |
| US20230349922A1 (en) | 2020-08-11 | 2023-11-02 | Université De Strasbourg | H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3458528A (en) * | 1965-07-07 | 1969-07-29 | Merck & Co Inc | Nitroimidazole carbonates and thionocarbonates |
| US3790593A (en) * | 1966-07-18 | 1974-02-05 | J Carlson | 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates |
| US3773781A (en) * | 1966-07-18 | 1973-11-20 | Merck & Co Inc | 1-substituted-5-nitroimidazol-2-ylalkyl-(n-substituted)-carbamates |
| BE758146A (fr) * | 1969-10-29 | 1971-04-28 | Smith Kline French Lab | Derives de l'amidine |
| US3759944A (en) * | 1970-10-14 | 1973-09-18 | Smith Kline French Lab | Isothioureas and their derivatives |
| ZA737629B (en) * | 1972-09-28 | 1974-12-24 | Searle & Co | 2-(2-(2-methyl-5-nitro-1-imidazolyl)ethyl)-2 thiopseudoureas and related compounds |
| GB1431589A (en) * | 1973-07-13 | 1976-04-07 | Smith Kline French Lab | Ureas, thioureas and guanidines n,n-disubstituted by heterocyclo- alkylene and/or heterocycloalkylenethioalkylene groups |
-
1975
- 1975-02-03 GB GB4538/75A patent/GB1542840A/en not_active Expired
-
1976
- 1976-01-07 ZA ZA00760082A patent/ZA7682B/xx unknown
- 1976-01-19 AU AU10394/76A patent/AU502509B2/en not_active Expired
- 1976-01-23 BE BE163748A patent/BE837848A/xx not_active IP Right Cessation
- 1976-01-27 US US05/652,925 patent/US4056621A/en not_active Expired - Lifetime
- 1976-01-29 NL NL7600906A patent/NL7600906A/xx not_active Application Discontinuation
- 1976-01-30 FR FR7602635A patent/FR2299026A1/fr active Granted
- 1976-01-31 JP JP51010795A patent/JPS6044302B2/ja not_active Expired
- 1976-02-02 CA CA244,784A patent/CA1067501A/en not_active Expired
- 1976-02-03 IE IE217/76A patent/IE42470B1/en unknown
- 1976-02-03 DE DE2604056A patent/DE2604056A1/de not_active Withdrawn
-
1983
- 1983-01-29 JP JP58013623A patent/JPS58150569A/ja active Granted
- 1983-01-29 JP JP58013622A patent/JPS58150568A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DE2604056A1 (de) | 1976-08-05 |
| NL7600906A (nl) | 1976-08-05 |
| FR2299026A1 (fr) | 1976-08-27 |
| JPS51101976A (it) | 1976-09-08 |
| JPS6044302B2 (ja) | 1985-10-02 |
| JPS58150568A (ja) | 1983-09-07 |
| AU1039476A (en) | 1977-07-28 |
| JPS58150569A (ja) | 1983-09-07 |
| GB1542840A (en) | 1979-03-28 |
| FR2299026B1 (it) | 1979-09-21 |
| IE42470L (en) | 1976-08-03 |
| AU502509B2 (en) | 1979-07-26 |
| US4056621A (en) | 1977-11-01 |
| BE837848A (fr) | 1976-07-23 |
| JPS6343391B2 (it) | 1988-08-30 |
| CA1067501A (en) | 1979-12-04 |
| IE42470B1 (en) | 1980-08-13 |
| JPS6343390B2 (it) | 1988-08-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA763652B (en) | Pharmacologically active compounds | |
| MW3476A1 (en) | Pharmacologically active compounds | |
| ZM14376A1 (en) | Pharmacologically active compounds | |
| PT67046A (en) | Pharmacologically active compounds | |
| PT65348A (en) | Pharmacologically active compounds | |
| ZA7682B (en) | Pharmacologically active compounds | |
| ZA765331B (en) | Novel pharmaceutically active compounds | |
| ZM9676A1 (en) | Pharmacologically active compounds | |
| ZM2677A1 (en) | Pharmacologically active compounds | |
| ZA761324B (en) | Pharmaceutically active compounds | |
| ZM9776A1 (en) | Pharmacologically active compounds | |
| ZA766778B (en) | Pharmacologically active compounds | |
| ZA762536B (en) | Pharmacologically active compounds | |
| ZA774220B (en) | Pharmacologically active compounds | |
| ZA774221B (en) | Pharmacologically active compounds | |
| ZA774552B (en) | Pharmacologically active compounds | |
| ZA774500B (en) | Pharmacologically active compounds | |
| ZA77508B (en) | Pharmacologically active compounds | |
| PT65759A (en) | Pharmacologically active compounds | |
| AU1059176A (en) | Pharmacologically active compositions | |
| ZM7377A1 (en) | Pharmacologically active compounds | |
| MW2776A1 (en) | Pharmacologically active compounds | |
| MW2876A1 (en) | Pharmacologically active compounds | |
| MW2676A1 (en) | Pharmacologically active compounds |